Inhibikase Therapeutics, Inc.
USD1.97
+0.04 (+1.81%)
CEO
Mark T. Iwicki
IPO Date
2020-12-23
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$1.93
Prev. Close
$1.93
Day Low
$1.92
Day High
$2.01
52W Low
$1.33
52W High
$2.26
Market Cap
$0.26B
Volume
0.94M
| -8.2 |
| 31 Dec 2023 | FY | -5127.8% | -7304.8% | -173.3% | -131.2% | 0.06 | 4.13 | -0.4 |
| 31 Dec 2022 | FY | 94.6% | -14625.9% | -85.8% | -72.4% | 0.02 | 6.59 | -0.7 |
| 31 Dec 2021 | FY | -266.4% | -476.9% | -38.5% | -34.8% | 0.01 | 10.47 | -1.8 |
| 31 Dec 2020 | FY | -28.0% | -407.7% | -29.1% | -19.3% | 0.03 | 3.13 | -24.4 |
| 31 Dec 2019 | FY | -127.4% | -509.7% | 127.5% | -14960.5% | -0.08 | 0.01 | -17.9 |
| 31 Dec 2018 | FY | 9.7% | -53.3% | 276.7% | -75.6% | -0.30 | 0.35 | -36.9 |
| 31 Dec 2017 | FY | 14.8% | -21.2% | 30.3% | -152.9% | -0.32 | 0.11 | -234.3 |
| 31 Dec 2016 | FY | 12.5% | -65.0% | 46.5% | -385.9% | -0.24 | 0.05 | -122.8 |
| -4.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -16.4% | -15.0% | 0.00 | 11.73 | -3.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -12.4% | -11.2% | 0.00 | 10.09 | -4.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -16.0% | -14.5% | 0.00 | 11.01 | -3.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -12.8% | -12.3% | 0.00 | 26.37 | -4.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 1089.0% | -132.0% | -0.41 | 0.85 | -0.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -97.3% | -56.2% | 0.07 | 2.32 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -68.6% | -42.0% | 0.07 | 2.55 | -0.7 |
| 31 Dec 2023 | Q4 | -656700.0% | -417794000.0% | -38.1% | -28.8% | 0.06 | 4.13 | -0.5 |